The closing price of Celularity Inc (NASDAQ: CELU) was $0.42 for the day, down -9.56% from the previous closing price of $0.46. In other words, the price has decreased by -$0.0444 from its previous closing price. On the day, 1176495 shares were traded. CELU stock price reached its highest trading level at $0.4696 during the session, while it also had its lowest trading level at $0.4022.
Ratios:
Our analysis of CELU’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 0.14 and its Current Ratio is at 0.19. In the meantime, Its Debt-to-Equity ratio is 2.02 whereas as Long-Term Debt/Eq ratio is at 0.86.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Morgan Stanley on January 30, 2023, Downgraded its rating to Underweight and sets its target price to $1 from $5 previously.
On June 22, 2022, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $15.H.C. Wainwright initiated its Buy rating on June 22, 2022, with a $15 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jan 12 when Lim Kok Thay bought 21,410,983 shares for $0.25 per share. The transaction valued at 5,331,335 led to the insider holds 51,473,762 shares of the business.
Hariri Robert J bought 9,357,585 shares of CELU for $1,484,113 on Oct 05. The Chief Executive Officer now owns 28,570,434 shares after completing the transaction at $0.16 per share. On Sep 29, another insider, Hariri Robert J, who serves as the Chief Executive Officer of the company, bought 9,064,539 shares for $0.17 each. As a result, the insider paid 1,500,181 and bolstered with 19,212,849 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CELU now has a Market Capitalization of 100.50M and an Enterprise Value of 161.30M. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.15 while its Price-to-Book (P/B) ratio in mrq is 2.69. Its current Enterprise Value per Revenue stands at 10.91 whereas that against EBITDA is -0.95.
Stock Price History:
Over the past 52 weeks, CELU has reached a high of $0.89, while it has fallen to a 52-week low of $0.16. The 50-Day Moving Average of the stock is 0.3084, while the 200-Day Moving Average is calculated to be 0.3651.
Shares Statistics:
CELU traded an average of 2.49M shares per day over the past three months and 416.28k shares per day over the past ten days. A total of 148.92M shares are outstanding, with a floating share count of 104.17M. Insiders hold about 51.87% of the company’s shares, while institutions hold 14.42% stake in the company. Shares short for CELU as of Jan 31, 2024 were 3.28M with a Short Ratio of 1.32, compared to 1.56M on Dec 29, 2023. Therefore, it implies a Short% of Shares Outstanding of 1.52% and a Short% of Float of 2.87%.
Earnings Estimates
The firm’s stock currently is rated by 0 analysts. On average, analysts expect EPS of $0 for the current quarter, with a high estimate of $0 and a low estimate of $0, while EPS last year was $0.16. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0. EPS for the following year is $0, with 0 analysts recommending between $0 and $0.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 1 analysts. It ranges from a high estimate of $4.71M to a low estimate of $4.71M. As of the current estimate, Celularity Inc’s year-ago sales were $4.13M, an estimated increase of 14.10% from the year-ago figure.
A total of 1 analysts have provided revenue estimates for CELU’s current fiscal year. The highest revenue estimate was $62.66M, while the lowest revenue estimate was $62.66M, resulting in an average revenue estimate of $62.66M. In the same quarter a year ago, actual revenue was $17.98M, up 248.60% from the average estimate. Based on 1 analysts’ estimates, the company’s revenue will be $19.63M in the next fiscal year. The high estimate is $19.63M and the low estimate is $19.63M. The average revenue growth estimate for next year is down -68.70% from the average revenue estimate for this year.
